Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random.
Dr. Minetta Liu is part of the team conducting a clinical trial to find biomarkers that will become an easy blood test for pancreatic cancer.
Dr. Jennifer Knox is leading the NeoPancONE trial for a biomarker that indicates which patients will respond better to certain chemotherapy before surgery.
When you start pancreatic cancer treatment it seems like everyone is speaking a language you don’t know. Here are 18 important words to help you along.
When Robert Weker was diagnosed with pancreatic cancer, he believed a clinical trial was his best chance of reducing the tumor enough for a Whipple.
Dr. Andrew Coveler explains how electric fields are being used to disrupt pancreatic cancer cell division, to make tumors more removable.
Medical research falls into one of three buckets: basic, clinical, and translational. Basic research is all about the nuts and bolts, demystifying at a fundamental level what makes a lethal disease like pancreatic cancer tick. Clinical research is all about patients, and finding out through rigorously controlled trials whether certain new drugs or other approaches […]
Why do clinical trials fail? What about the patients on the trial? Learn more about what happens when pancreatic cancer clinical trials fail.
When treatment stopped working for Adam Deal, genetic testing of his tumor RNA found a mutation that made him eligible to try a new drug.